+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Sunitinib Malate Market by Purity, Indication - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 196 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 5889407
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Sunitinib Malate Market grew from USD 123.27 million in 2023 to USD 134.72 million in 2024. It is expected to continue growing at a CAGR of 9.79%, reaching USD 237.13 million by 2030.

Sunitinib Malate is a targeted cancer therapy, specifically a tyrosine kinase inhibitor, used primarily to treat specific types of cancers such as renal cell carcinoma and gastrointestinal stromal tumors. The necessity of Sunitinib Malate arises from its targeted approach, offering a more precise treatment with potentially fewer side effects compared to conventional chemotherapy. Its application is primarily in oncology, focusing on inhibiting cancer growth and metastasis through its mechanism of action that interferes with cell signaling pathways. The end-use scope predominantly covers hospitals, oncology clinics, and specialized cancer treatment centers.

The market for Sunitinib Malate is heavily influenced by factors such as the increasing prevalence of cancer globally, advancements in precision medicine, and rising healthcare expenditures. Potential opportunities lie in emerging markets where healthcare infrastructure is expanding and regulatory pathways are becoming more streamlined for faster approval of new therapies. Additionally, ongoing research into combination therapies and novel formulations presents avenues for differentiation and market expansion. However, limitations include high treatment costs, potential adverse effects, and patent expirations that may lead to generic competition, affecting market share for original manufacturers.

To mitigate these challenges and foster growth, innovation can be directed towards developing biosimilars to make treatment more accessible, improving administration routes, and personalizing therapies based on genetic markers. Business growth can be bolstered by strategic partnerships for R&D, focused on widening therapeutic indications and enhancing patient adherence through better delivery systems. Insight into the nature of the market reveals it as highly competitive, with substantial emphasis on clinical outcomes and patient-centric approaches. To capitalize on growth opportunities, stakeholders must invest in rigorous clinical trials and real-world evidence to substantiate the efficacy and safety of Sunitinib Malate in diverse patient populations while exploring digital health integration for real-time monitoring and tailored patient support systems.

Understanding Market Dynamics in the Sunitinib Malate Market

The Sunitinib Malate Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Rise in prevalence of pancreatic neuroendocrine tumors (pNET)
    • Availability of limited drug options for treatment of advanced pNET
  • Market Restraints
    • High cost of raw materials for manufacturing of sunitinib malate drug
  • Market Opportunities
    • Ongoing research and development by pharmaceutical companies to explore new indications and combinations for sunitinib malate
    • Increasing awareness about the benefits of targeted therapies in cancer treatment among patients and healthcare providers
  • Market Challenges
    • Adverse cardiovascular events reported during clinical trials

Exploring Porter’s Five Forces for the Sunitinib Malate Market

Porter’s Five Forces framework further strengthens the insights of the Sunitinib Malate Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Sunitinib Malate Market

External macro-environmental factors deeply influence the performance of the Sunitinib Malate Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Sunitinib Malate Market

The Sunitinib Malate Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Sunitinib Malate Market

The Sunitinib Malate Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Sunitinib Malate Market

The Sunitinib Malate Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Sunitinib Malate Market, highlighting leading vendors and their innovative profiles. These include Aark Pharmaceuticals, Active Biotech AB, Anant Pharmaceuticals Pvt. Ltd., AstraZeneca PLC, Beijing Lunarsun Pharmaceutical Co., Ltd., Bio-Techne Corporation, Brawn Laboratories Ltd., Hetero Labs Limited, Hikma Pharmaceuticals PLC, JEIL PHARMACEUTICAL CO.,LTD., Manus Aktteva Biopharma LLP, Medichem S.A., Medzeel Lifescience, Nanjing First Pharmaceutical Co. Ltd,, Natco Pharma Limited, Pfizer Inc., Shilpa Medicare Limited, Sichuan Xieli Pharmaceutical Co., Ltd., Synthland Limited, Taj Pharma India Limited, TargetMol Chemicals Inc., Teva Pharmaceutical Industries Ltd., and Vivan Life Science.

Market Segmentation & Coverage

This research report categorizes the Sunitinib Malate Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Purity
    • >97%
    • >98%
    • >99%
  • Indication
    • Gastrointestinal Stromal Tumors (GISTs)
    • Pancreatic Neuroendocrine Tumors
    • Renal Cell Carcinoma (RCC)
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rise in prevalence of pancreatic neuroendocrine tumors (pNET)
5.1.1.2. Availability of limited drug options for treatment of advanced pNET
5.1.2. Restraints
5.1.2.1. High cost of raw materials for manufacturing of sunitinib malate drug
5.1.3. Opportunities
5.1.3.1. Ongoing research and development by pharmaceutical companies to explore new indications and combinations for sunitinib malate
5.1.3.2. Increasing awareness about the benefits of targeted therapies in cancer treatment among patients and healthcare providers
5.1.4. Challenges
5.1.4.1. Adverse cardiovascular events reported during clinical trials
5.2. Market Segmentation Analysis
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Sunitinib Malate Market, by Purity
6.1. Introduction
6.2. >97%
6.3. >98%
6.4. >99%
7. Sunitinib Malate Market, by Indication
7.1. Introduction
7.2. Gastrointestinal Stromal Tumors (GISTs)
7.3. Pancreatic Neuroendocrine Tumors
7.4. Renal Cell Carcinoma (RCC)
8. Americas Sunitinib Malate Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States
9. Asia-Pacific Sunitinib Malate Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam
10. Europe, Middle East & Africa Sunitinib Malate Market
10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom
11. Competitive Landscape
11.1. Market Share Analysis, 2023
11.2. FPNV Positioning Matrix, 2023
11.3. Competitive Scenario Analysis
11.4. Strategy Analysis & Recommendation
List of Figures
FIGURE 1. SUNITINIB MALATE MARKET RESEARCH PROCESS
FIGURE 2. SUNITINIB MALATE MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL SUNITINIB MALATE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL SUNITINIB MALATE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL SUNITINIB MALATE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL SUNITINIB MALATE MARKET SIZE, BY PURITY, 2023 VS 2030 (%)
FIGURE 7. GLOBAL SUNITINIB MALATE MARKET SIZE, BY PURITY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL SUNITINIB MALATE MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
FIGURE 9. GLOBAL SUNITINIB MALATE MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. AMERICAS SUNITINIB MALATE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 11. AMERICAS SUNITINIB MALATE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. UNITED STATES SUNITINIB MALATE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 13. UNITED STATES SUNITINIB MALATE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. ASIA-PACIFIC SUNITINIB MALATE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 15. ASIA-PACIFIC SUNITINIB MALATE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. EUROPE, MIDDLE EAST & AFRICA SUNITINIB MALATE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA SUNITINIB MALATE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. SUNITINIB MALATE MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 19. SUNITINIB MALATE MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. SUNITINIB MALATE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL SUNITINIB MALATE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL SUNITINIB MALATE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL SUNITINIB MALATE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. SUNITINIB MALATE MARKET DYNAMICS
TABLE 7. GLOBAL SUNITINIB MALATE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL SUNITINIB MALATE MARKET SIZE, BY >97%, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL SUNITINIB MALATE MARKET SIZE, BY >98%, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL SUNITINIB MALATE MARKET SIZE, BY >99%, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL SUNITINIB MALATE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL SUNITINIB MALATE MARKET SIZE, BY GASTROINTESTINAL STROMAL TUMORS (GISTS), BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL SUNITINIB MALATE MARKET SIZE, BY PANCREATIC NEUROENDOCRINE TUMORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL SUNITINIB MALATE MARKET SIZE, BY RENAL CELL CARCINOMA (RCC), BY REGION, 2018-2030 (USD MILLION)
TABLE 15. AMERICAS SUNITINIB MALATE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
TABLE 16. AMERICAS SUNITINIB MALATE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 17. AMERICAS SUNITINIB MALATE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 18. ARGENTINA SUNITINIB MALATE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
TABLE 19. ARGENTINA SUNITINIB MALATE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 20. BRAZIL SUNITINIB MALATE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
TABLE 21. BRAZIL SUNITINIB MALATE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 22. CANADA SUNITINIB MALATE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
TABLE 23. CANADA SUNITINIB MALATE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 24. MEXICO SUNITINIB MALATE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
TABLE 25. MEXICO SUNITINIB MALATE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 26. UNITED STATES SUNITINIB MALATE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
TABLE 27. UNITED STATES SUNITINIB MALATE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 28. UNITED STATES SUNITINIB MALATE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 29. ASIA-PACIFIC SUNITINIB MALATE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
TABLE 30. ASIA-PACIFIC SUNITINIB MALATE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 31. ASIA-PACIFIC SUNITINIB MALATE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 32. AUSTRALIA SUNITINIB MALATE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
TABLE 33. AUSTRALIA SUNITINIB MALATE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 34. CHINA SUNITINIB MALATE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
TABLE 35. CHINA SUNITINIB MALATE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 36. INDIA SUNITINIB MALATE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
TABLE 37. INDIA SUNITINIB MALATE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 38. INDONESIA SUNITINIB MALATE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
TABLE 39. INDONESIA SUNITINIB MALATE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 40. JAPAN SUNITINIB MALATE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
TABLE 41. JAPAN SUNITINIB MALATE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 42. MALAYSIA SUNITINIB MALATE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
TABLE 43. MALAYSIA SUNITINIB MALATE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 44. PHILIPPINES SUNITINIB MALATE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
TABLE 45. PHILIPPINES SUNITINIB MALATE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 46. SINGAPORE SUNITINIB MALATE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
TABLE 47. SINGAPORE SUNITINIB MALATE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 48. SOUTH KOREA SUNITINIB MALATE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
TABLE 49. SOUTH KOREA SUNITINIB MALATE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 50. TAIWAN SUNITINIB MALATE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
TABLE 51. TAIWAN SUNITINIB MALATE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 52. THAILAND SUNITINIB MALATE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
TABLE 53. THAILAND SUNITINIB MALATE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 54. VIETNAM SUNITINIB MALATE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
TABLE 55. VIETNAM SUNITINIB MALATE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 56. EUROPE, MIDDLE EAST & AFRICA SUNITINIB MALATE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
TABLE 57. EUROPE, MIDDLE EAST & AFRICA SUNITINIB MALATE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 58. EUROPE, MIDDLE EAST & AFRICA SUNITINIB MALATE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 59. DENMARK SUNITINIB MALATE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
TABLE 60. DENMARK SUNITINIB MALATE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 61. EGYPT SUNITINIB MALATE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
TABLE 62. EGYPT SUNITINIB MALATE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 63. FINLAND SUNITINIB MALATE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
TABLE 64. FINLAND SUNITINIB MALATE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 65. FRANCE SUNITINIB MALATE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
TABLE 66. FRANCE SUNITINIB MALATE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 67. GERMANY SUNITINIB MALATE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
TABLE 68. GERMANY SUNITINIB MALATE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 69. ISRAEL SUNITINIB MALATE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
TABLE 70. ISRAEL SUNITINIB MALATE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 71. ITALY SUNITINIB MALATE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
TABLE 72. ITALY SUNITINIB MALATE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 73. NETHERLANDS SUNITINIB MALATE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
TABLE 74. NETHERLANDS SUNITINIB MALATE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 75. NIGERIA SUNITINIB MALATE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
TABLE 76. NIGERIA SUNITINIB MALATE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 77. NORWAY SUNITINIB MALATE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
TABLE 78. NORWAY SUNITINIB MALATE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 79. POLAND SUNITINIB MALATE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
TABLE 80. POLAND SUNITINIB MALATE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 81. QATAR SUNITINIB MALATE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
TABLE 82. QATAR SUNITINIB MALATE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 83. RUSSIA SUNITINIB MALATE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
TABLE 84. RUSSIA SUNITINIB MALATE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 85. SAUDI ARABIA SUNITINIB MALATE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
TABLE 86. SAUDI ARABIA SUNITINIB MALATE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 87. SOUTH AFRICA SUNITINIB MALATE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
TABLE 88. SOUTH AFRICA SUNITINIB MALATE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 89. SPAIN SUNITINIB MALATE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
TABLE 90. SPAIN SUNITINIB MALATE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 91. SWEDEN SUNITINIB MALATE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
TABLE 92. SWEDEN SUNITINIB MALATE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 93. SWITZERLAND SUNITINIB MALATE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
TABLE 94. SWITZERLAND SUNITINIB MALATE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 95. TURKEY SUNITINIB MALATE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
TABLE 96. TURKEY SUNITINIB MALATE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 97. UNITED ARAB EMIRATES SUNITINIB MALATE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
TABLE 98. UNITED ARAB EMIRATES SUNITINIB MALATE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 99. UNITED KINGDOM SUNITINIB MALATE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
TABLE 100. UNITED KINGDOM SUNITINIB MALATE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 101. SUNITINIB MALATE MARKET SHARE, BY KEY PLAYER, 2023
TABLE 102. SUNITINIB MALATE MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Sunitinib Malate Market, which are profiled in this report, include:
  • Aark Pharmaceuticals
  • Active Biotech AB
  • Anant Pharmaceuticals Pvt. Ltd.
  • AstraZeneca PLC
  • Beijing Lunarsun Pharmaceutical Co., Ltd.
  • Bio-Techne Corporation
  • Brawn Laboratories Ltd.
  • Hetero Labs Limited
  • Hikma Pharmaceuticals PLC
  • JEIL PHARMACEUTICAL CO.,LTD.
  • Manus Aktteva Biopharma LLP
  • Medichem S.A.
  • Medzeel Lifescience
  • Nanjing First Pharmaceutical Co. Ltd,
  • Natco Pharma Limited
  • Pfizer Inc.
  • Shilpa Medicare Limited
  • Sichuan Xieli Pharmaceutical Co., Ltd.
  • Synthland Limited
  • Taj Pharma India Limited
  • TargetMol Chemicals Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Vivan Life Science

Methodology

Loading
LOADING...

Table Information